Calcium Gluconate Patent Expiration

Calcium Gluconate is used for treating high blood pressure and heart failure. It was first introduced by Fresenius Kabi Usa Llc in its drug Calcium Gluconate on Jun 15, 2017. Another drug containing Calcium Gluconate is Calcium Gluconate In Sodium Chloride. 6 different companies have introduced drugs containing Calcium Gluconate.


Calcium Gluconate Patents

Given below is the list of patents protecting Calcium Gluconate, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Calcium Gluconate In Sodium Chloride US10130646 Calcium gluconate solutions in flexible containers Jul 25, 2037 Hq Spclt Pharma
Calcium Gluconate In Sodium Chloride US10342813 Calcium gluconate solutions in flexible containers Jul 25, 2037 Hq Spclt Pharma



Calcium Gluconate's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Calcium Gluconate Generic API Manufacturers

Several generic applications have been filed for Calcium Gluconate. The first generic version for Calcium Gluconate was by Nivagen Pharmaceuticals Inc and was approved on Oct 14, 2022. And the latest generic version is by Amneal Eu Ltd and was approved on May 10, 2024.

Given below is the list of companies who have filed for Calcium Gluconate generic, along with the locations of their manufacturing plants worldwide.